[go: up one dir, main page]

ZA872705B - Human g-csf protein expression - Google Patents

Human g-csf protein expression

Info

Publication number
ZA872705B
ZA872705B ZA872705A ZA872705A ZA872705B ZA 872705 B ZA872705 B ZA 872705B ZA 872705 A ZA872705 A ZA 872705A ZA 872705 A ZA872705 A ZA 872705A ZA 872705 B ZA872705 B ZA 872705B
Authority
ZA
South Africa
Prior art keywords
human
protein expression
csf protein
csf
expression
Prior art date
Application number
ZA872705A
Inventor
Pat Cerretti Douglas
John Cosman David
Gillis Steven
Yukiko Mochizuki Diane
Jack March Carl
Lee Price Virginia
J. Tushinski Robert
Lloyd Urdal David
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of ZA872705B publication Critical patent/ZA872705B/en

Links

ZA872705A 1986-04-22 1987-04-15 Human g-csf protein expression ZA872705B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85664386A 1986-04-22 1986-04-22

Publications (1)

Publication Number Publication Date
ZA872705B true ZA872705B (en) 1987-10-05

Family

ID=25324150

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872705A ZA872705B (en) 1986-04-22 1987-04-15 Human g-csf protein expression

Country Status (2)

Country Link
JP (1) JPS63299A (en)
ZA (1) ZA872705B (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2629000B2 (en) * 1986-07-18 1997-07-09 中外製薬株式会社 Stable granulocyte colony stimulating factor-containing preparation
JP2628961B2 (en) * 1986-12-23 1997-07-09 協和醗酵工業株式会社 Novel polypeptide
CA2736981A1 (en) 1998-04-14 1999-10-21 Kyowa Hakko Bio Co., Ltd. Process for producing isoprenoid compounds by microorganisms
JP4474496B2 (en) 1998-06-02 2010-06-02 学校法人日本大学 IgA nephropathy-related DNA
EA013224B1 (en) 2000-10-06 2010-04-30 Киова Хакко Кирин Ко., Лтд. Cells producing antibody compositions
CN100400660C (en) 2002-12-26 2008-07-09 协和发酵工业株式会社 Method for producing dipeptides
US20110189233A1 (en) 2004-03-05 2011-08-04 Kazuhiro Nagaike Recombinant Varicella-Zoster Virus
JP4705026B2 (en) 2004-03-19 2011-06-22 ジェノミディア株式会社 Vascular endothelial growth promoting gene
JP3996627B2 (en) 2004-07-22 2007-10-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 Lrp4 / Corin dopaminergic neuron progenitor cell marker
EP1930344A4 (en) 2005-09-29 2008-12-31 Shionogi & Co Polypeptide having anti-angiogenic activity
EP2471937A3 (en) 2005-11-24 2013-04-24 The Research Foundation for Microbial Diseases of Osaka University Recombinant polyvalent vaccine
WO2007063866A1 (en) 2005-11-29 2007-06-07 Kyowa Hakko Kogyo Co., Ltd. Novel protein and dna encoding the protein
WO2007066698A1 (en) 2005-12-06 2007-06-14 Kyowa Hakko Kogyo Co., Ltd. Genetically recombinant anti-perp antibody
JP5242382B2 (en) 2006-04-14 2013-07-24 株式会社医学生物学研究所 Polypeptide variant having effector function
AU2007257646B2 (en) 2006-06-06 2011-08-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
WO2008038613A1 (en) 2006-09-25 2008-04-03 Kyowa Hakko Bio Co., Ltd. Method for production of dipeptide
US20110236374A1 (en) 2007-01-24 2011-09-29 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
CA2676529C (en) 2007-01-24 2014-03-25 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition having enhanced effector activity
US20100075343A1 (en) 2007-01-25 2010-03-25 Motoo Yamasaki Novel peptides
EP2138576A4 (en) 2007-03-16 2011-02-23 Kyowa Hakko Kirin Co Ltd Anti-claudin-4 antibody
WO2008123308A1 (en) 2007-03-29 2008-10-16 National University Corporation Okayama University Therapeutic agent comprising vasohibin
CN101878306A (en) 2007-09-27 2010-11-03 盐野义制药株式会社 Method for producing hydroxylated adamantane using cytochrome P450
WO2009054435A1 (en) 2007-10-24 2009-04-30 Otsuka Chemical Co., Ltd. Polypeptide having enhanced effector function
CN101978054B (en) 2007-12-05 2013-05-29 协和发酵麒麟株式会社 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
CN102007147B (en) 2008-06-30 2014-11-05 协和发酵麒麟株式会社 Anti-CD27 antibody
CN103172735B (en) 2008-07-17 2014-12-10 协和发酵麒麟株式会社 Anti-system asc amino acid transporter 2 (asct2) antibody
WO2010018847A1 (en) 2008-08-13 2010-02-18 協和発酵キリン株式会社 Recombinant protein-s composition
WO2010074266A1 (en) 2008-12-26 2010-07-01 協和発酵キリン株式会社 Anti-cd4 antibody
NZ595825A (en) 2009-04-20 2012-10-26 Kyowa Hakko Kirin Co Ltd Antibody containing igg2 having amino acid mutation introduced therein
KR20120110141A (en) 2009-12-28 2012-10-09 교와 핫꼬 기린 가부시키가이샤 Anti-iga1 antibody
AU2011222012C1 (en) 2010-03-02 2015-02-26 Kyowa Kirin Co., Ltd. Modified antibody composition
ES2682078T3 (en) 2010-06-11 2018-09-18 Kyowa Hakko Kirin Co., Ltd. Anti-TIM-3 antibody
JP5058332B2 (en) 2010-07-14 2012-10-24 住友ゴム工業株式会社 Isoprene oligomer, polyisoprene, and production methods thereof, rubber composition, and pneumatic tire
CN103781800A (en) 2011-06-20 2014-05-07 协和发酵麒麟株式会社 Anti-erbB3 antibody
CN104411720B (en) 2012-07-02 2018-05-11 协和发酵麒麟株式会社 Therapeutic agent using anti-BMP9 antibody as active ingredient, to anaemias such as renal anemia, cancer-related anemias
US9714291B2 (en) 2012-10-05 2017-07-25 Kyowa Hakko Kirin Co., Ltd Heterodimer protein composition
KR20150094617A (en) 2012-12-07 2015-08-19 교와 핫꼬 기린 가부시키가이샤 Anti-folr1 antibody
US9944970B2 (en) 2013-07-09 2018-04-17 Kyowa Medex Co., Ltd. Glycated hexapeptide oxidase and use thereof
EP3653713A4 (en) 2017-07-13 2021-03-31 Kyowa Kirin Co., Ltd. ANTI-BRIL ANTIBODIES AND PROCEDURE FOR STABILIZING THE BRIL FUSION PROTEIN WITH THIS ANTIBODY
TW201908341A (en) 2017-07-18 2019-03-01 日商協和醱酵麒麟有限公司 Anti-human CCR1 monoclonal antibody
CA3081854A1 (en) 2017-11-08 2019-05-16 Kyowa Kirin Co., Ltd. Bispecific antibody which binds to cd40 and epcam
WO2019117208A1 (en) 2017-12-12 2019-06-20 協和発酵キリン株式会社 Anti-bmp10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising said antibody as active ingredient
KR20210025023A (en) 2018-06-26 2021-03-08 쿄와 기린 가부시키가이샤 Antibodies that bind to chondroitin sulfate proteoglycan-5
JP7397445B2 (en) 2018-06-26 2023-12-13 協和キリン株式会社 Antibody that binds to Cell Adhesion Molecule 3
TW202028467A (en) 2018-09-28 2020-08-01 日商協和麒麟股份有限公司 Antibody composition
MX2021007797A (en) 2018-12-28 2021-10-26 Kyowa Kirin Co Ltd BISPECIFIC ANTIBODY BINDING TO TfR.
US20220220216A1 (en) 2019-05-15 2022-07-14 Kyowa Kirin Co., Ltd. Bispecific antibody binding to cd40 and gpc3
AU2020276931A1 (en) 2019-05-15 2021-12-16 Kyowa Kirin Co., Ltd. Bispecific antibody binding to CD40 and FAP
AU2020346580A1 (en) 2019-09-13 2022-03-31 Kyowa Kirin Co., Ltd. DcR3 variant
US20220380489A1 (en) 2019-10-02 2022-12-01 Kyushu University, National University Corporation Method for producing heparin-like substance, recombinant cell, and method for producing the same
TW202140561A (en) 2020-02-14 2021-11-01 日商協和麒麟股份有限公司 Bispecific antibody that binds to CD3
AU2021249888A1 (en) 2020-04-01 2022-10-27 Kyowa Kirin Co., Ltd. Antibody composition
CN117836326A (en) 2021-08-26 2024-04-05 协和麒麟株式会社 Bispecific antibodies binding to CD116 and CD131
TW202342518A (en) 2022-02-09 2023-11-01 國立研究開發法人醫藥基盤 健康 營養研究所 Antibody or fragment thereof that binds to FCRL1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227526A (en) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd Novel csf and method of collecting same
JPH06102021B2 (en) * 1985-12-03 1994-12-14 中外製薬株式会社 Novel polypeptide
JPH0657152B2 (en) * 1985-09-17 1994-08-03 中外製薬株式会社 CSF genes

Also Published As

Publication number Publication date
JPS63299A (en) 1988-01-05

Similar Documents

Publication Publication Date Title
ZA872705B (en) Human g-csf protein expression
AU7184487A (en) Human g-csf protein expression
ZA885789B (en) Skin care compositions
EP0272149A3 (en) Medical dresssings
HU906229D0 (en) Medical preparations
GB8709118D0 (en) Robotic skin
NZ223827A (en) Skin substitute
IL81175A0 (en) Human preproinsulin-like factor i
ZA881780B (en) Skin care compositions
GB2196253B (en) Dentifrice gel
GB2181349B (en) Skin care composition
PH23914A (en) Cosmetic
GB8613431D0 (en) Human tachykinins
GB8503654D0 (en) Human skin substitute
GB8715489D0 (en) Skin care compositions
GB8729251D0 (en) Human cytomegalovirus protein
GB8603079D0 (en) Skin care preparation
GB2195250B (en) Medical vapourizer
GB2171013B (en) Skin care composition
GB8725462D0 (en) Protein
GB8610192D0 (en) Tissue stimulator
PT86162A (en) Recombinant protein expression
JPS6410000A (en) Human splenine
GB8725463D0 (en) Protein
GB8714855D0 (en) Skin treatment compositions